Oxymetazoline 1% cream in erythema of rosacea: a profile of its use in the USA

[1]  L. Baumann,et al.  Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials , 2018, Journal of drugs in dermatology : JDD.

[2]  M. Lebwohl,et al.  Daily oxymetazoline cream demonstrates high and sustained efficacy in patients with persistent erythema of rosacea through 52 weeks of treatment. , 2018, Journal of the American Academy of Dermatology.

[3]  E. Hsia,et al.  Reduction in ultraviolet B light–induced erythema by oxymetazoline and brimonidine is mediated by different α‐adrenoceptors , 2018, Experimental dermatology.

[4]  L. Baumann,et al.  Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52‐week open label REVEAL trial , 2018, Journal of the American Academy of Dermatology.

[5]  J. Dover,et al.  Clinically Relevant Reduction in Persistent Facial Erythema of Rosacea on the First Day of Treatment With Oxymetazoline Cream 1.0. , 2018, Journal of drugs in dermatology : JDD.

[6]  J. Dover,et al.  Phase 2 Randomized, Dose-Ranging Study of Oxymetazoline Cream for Treatment of Persistent Facial Erythema Associated With Rosacea. , 2018, Journal of drugs in dermatology : JDD.

[7]  S. Feldman,et al.  Quality of Life in Individuals with Erythematotelangiectatic and Papulopustular Rosacea: Findings From a Web-based Survey. , 2018, The Journal of clinical and aesthetic dermatology.

[8]  J. Harper,et al.  Cross-Sectional Survey of the Burden of Illness of Rosacea by Erythema Severity. , 2018, Journal of drugs in dermatology : JDD.

[9]  M. Attar,et al.  Clinical Pharmacokinetics of Oxymetazoline Cream Following Topical Facial Administration for the Treatment of Erythema Associated With Rosacea. , 2018, Journal of drugs in dermatology : JDD.

[10]  A. Pathak,et al.  In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea , 2018, Drugs in R&D.

[11]  Z. Draelos,et al.  New and Emerging Treatments for Rosacea , 2015, American Journal of Clinical Dermatology.

[12]  H. Muncie,et al.  Rosacea: Diagnosis and Treatment. , 2015, American family physician.

[13]  J. D. Del Rosso,et al.  Management of cutaneous rosacea: emphasis on new medical therapies , 2014, Expert opinion on pharmacotherapy.

[14]  S. Feldman,et al.  Rosacea: New and Emerging Treatments , 2014, Drugs.

[15]  D. Thiboutot,et al.  Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 1: a status report on the disease state, general measures, and adjunctive skin care. , 2013, Cutis.

[16]  Z. Draelos,et al.  Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial. , 2018, Journal of drugs in dermatology : JDD.

[17]  L. Baumann,et al.  Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial. , 2018, Journal of drugs in dermatology : JDD.

[18]  J. D. Del Rosso.  Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now? , 2017, The Journal of clinical and aesthetic dermatology.